These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21935155)
21. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings. Asgary R; Beideck E; Naderi R Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209 [TBL] [Abstract][Full Text] [Related]
22. Diffuse reflectance spectroscopy as a tool to measure the absorption coefficient in skin: system calibration. Karsten AE; Singh A; Karsten PA; Braun MW Lasers Med Sci; 2013 Feb; 28(2):437-44. PubMed ID: 22410734 [TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening and prevention in low-resource settings. Bradford L; Goodman A Clin Obstet Gynecol; 2013 Mar; 56(1):76-87. PubMed ID: 23337844 [TBL] [Abstract][Full Text] [Related]
25. Monte Carlo lookup table-based inverse model for extracting optical properties from tissue-simulating phantoms using diffuse reflectance spectroscopy. Hennessy R; Lim SL; Markey MK; Tunnell JW J Biomed Opt; 2013 Mar; 18(3):037003. PubMed ID: 23455965 [TBL] [Abstract][Full Text] [Related]
26. Elastic light single-scattering spectroscopy for the detection of cervical precancerous ex vivo. Denkçeken T; Simşek T; Erdoğan G; Peştereli E; Karaveli S; Özel D; Bilge U; Canpolat M IEEE Trans Biomed Eng; 2013 Jan; 60(1):123-7. PubMed ID: 23144024 [TBL] [Abstract][Full Text] [Related]
27. ACA-Pro: calibration protocol for quantitative diffuse reflectance spectroscopy. Validation on contact and noncontact probe- and CCD-based systems. Sorgato V; Berger M; Emain C; Vever-Bizet C; Dinten JM; Bourg-Heckly G; Planat-Chrétien A J Biomed Opt; 2016 Jun; 21(6):65003. PubMed ID: 27281063 [TBL] [Abstract][Full Text] [Related]
28. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides. Tsiambas E; Riziotis C Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686 [TBL] [Abstract][Full Text] [Related]
29. Accuracy of visual inspection with acetic acid and with Lugol's iodine for cervical cancer screening: Meta-analysis. Qiao L; Li B; Long M; Wang X; Wang A; Zhang G J Obstet Gynaecol Res; 2015 Sep; 41(9):1313-25. PubMed ID: 26014371 [TBL] [Abstract][Full Text] [Related]
30. A Clinical Study to Assess Diffuse Reflectance Spectroscopy with an Auto-Calibrated, Pressure-Sensing Optical Probe in Head and Neck Cancer. Rickard AG; Mikati H; Mansourati A; Stevenson D; Krieger M; Rocke D; Esclamado R; Dewhirst MW; Ramanujam N; Lee WT; Palmer GM Curr Oncol; 2023 Feb; 30(3):2751-2760. PubMed ID: 36975421 [TBL] [Abstract][Full Text] [Related]
31. [Value of acetic acid smear test for cervical cancer screening]. Wu LY; Li N; Zhang WH; Li L; Pan QJ; Qiao YL; Rong SD; Zhao FH; Pretorius RG; Belinson JL Ai Zheng; 2003 Oct; 22(10):1096-8. PubMed ID: 14558960 [TBL] [Abstract][Full Text] [Related]
32. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765 [TBL] [Abstract][Full Text] [Related]
33. Diffuse reflectance spectroscopy of epithelial tissue with a smart fiber-optic probe. Yu B; Shah A; Nagarajan VK; Ferris DG Biomed Opt Express; 2014 Mar; 5(3):675-89. PubMed ID: 24688805 [TBL] [Abstract][Full Text] [Related]
34. Recent advances in optical imaging for cervical cancer detection. Orfanoudaki IM; Kappou D; Sifakis S Arch Gynecol Obstet; 2011 Nov; 284(5):1197-208. PubMed ID: 21800084 [TBL] [Abstract][Full Text] [Related]
35. Comparative Study of Smart Scope® Visual Screening Test with Naked Eye Visual Screening and Pap Test. Rahatgaonkar V; Uchale P; Oka G Asian Pac J Cancer Prev; 2020 Dec; 21(12):3509-3515. PubMed ID: 33369446 [TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta. Campos NG; Scarinci IC; Tucker L; Peral S; Li Y; Regan MC; Sy S; Castle PE; Kim JJ Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1114-1121. PubMed ID: 33771846 [TBL] [Abstract][Full Text] [Related]
37. Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting. Holmström O; Linder N; Kaingu H; Mbuuko N; Mbete J; Kinyua F; Törnquist S; Muinde M; Krogerus L; Lundin M; Diwan V; Lundin J JAMA Netw Open; 2021 Mar; 4(3):e211740. PubMed ID: 33729503 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations. Suchońska B; Gajzlerska-Majewska W; Wielgoś M PLoS One; 2021; 16(2):e0247702. PubMed ID: 33635909 [TBL] [Abstract][Full Text] [Related]
40. A direct comparison of four high-risk human papillomavirus tests versus the cobas test: Detecting CIN2+ in low-resource settings. Xue P; Gao LL; Yin J; Han LL; Zhao J; Li L; Seery S; Han XY; Li TY; Jiang Y; Chen W; Shen J J Med Virol; 2019 Jul; 91(7):1342-1350. PubMed ID: 30854653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]